Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hexamidine is a synthetic diamidine compound primarily used as an antiseptic and disinfectant. It exhibits broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria, fungi, and protozoa. Its mechanism of action involves disrupting the cell membranes of microorganisms, leading to cell death, and it may also inhibit the synthesis of nucleic acids. Originally synthesized in 1939 by May & Baker as a trypanocide, Hexamidine is now widely utilized in topical medications, personal care products, antiseptic solutions, wound dressings, and ophthalmic solutions for various indications, including skin infections, acne, rosacea, seborrheic dermatitis, and Acanthamoeba keratitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hexamidine.